SCHEMBL15083039

SCHEMBL15083039

COB(O)c1ccc(Cl)c(OC)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEP1B Q16820 1/20 0.40
TAS1R3 Q7RTX0 3/20 0.36
TAS1R1 Q7RTX1 3/20 0.36
TAS1R2 Q8TE23 2/20 0.36
TSHR P16473 1/20 0.34
TUBB4A P04350 2/20 0.31
TUBB P07437 2/20 0.31
TUBA3C P0DPH7 2/20 0.31
TUBA1B P68363 2/20 0.31
TUBA4A P68366 2/20 0.31
TUBB4B P68371 2/20 0.31
TUBB3 Q13509 2/20 0.31
TUBB2A Q13885 2/20 0.31
TUBB8 Q3ZCM7 2/20 0.31
TUBA3E Q6PEY2 2/20 0.31
TUBA1A Q71U36 2/20 0.31
TUBA1C Q9BQE3 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951760 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL718784 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL14665871 0.86 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL15065240 0.84 MEP1B (0.38) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL14665872 0.84 ALDH1A1 (0.38) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL19209983 0.82 MEP1B (0.34) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL11903213 0.81 MEP1B (0.36) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL11903215 0.79 MEP1B (0.34) ALDH1A1KDM4EHSD17B10MEP1B
SCHEMBL18244619 0.74 ALDH1A1 (0.45) ALDH1A1KDM4EHSD17B10MEP1BTAS1R3
SCHEMBL18359227 0.74 AR (0.33) MEP1BTUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130172566-A1 METHODS OF PRODUCING METHYL 4-AMINO-3-CHLORO-6-(4-CHLORO-2-FLUORO-3-METHOXYPHENYL)PYRIDINE-2-CARBOXYLATE DOW AGROSCIENCES LLC (US) 2013-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172566-A1 METHODS OF PRODUCING METHYL 4-AMINO-3-CHLORO-6-(4-CHLORO-2-FLUORO-3-METHOXYPHENYL)PYRIDINE-2-CARBOXYLATE KDM6B, JMJD6, MPHOSPH6 ALDH1A1 815/4885KDM4E 61/4885HSD17B10 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.